ADHD Patients Receive Personalized Treatment with Affordable, New Harmonyx Genetic Test

When facing an ADHD diagnosis, for you or your child, it can be scary. With so many ADHD medications out there, how do you determine which is the best fit? The Harmonyx® Test for ADHD can help eliminate that problem. Harmonyx, a leading company in affordable and accessible genetic testing, understands the need for affordable, personalized medicine.

“We are seeing all too often a trial-and-error approach to the prescription process,” said Bob Bean, President and CEO of Harmonyx. “This is a slow and inadequate way to help those diagnosed with ADHD get the effective treatment they need. Our affordable new test gives caregivers, parents and patients the ability to make informed decisions about the medications they choose.”

For less than $100, ADHD patients take a simple swab sample that tests four strands of genes to determine which medications will metabolize effectively or ineffectively in their bodies. The test considers more than 20 ADHD medications, including Adderall®, Vyvanse®, Ritalin®, Strattera® and Dexedrine®. The results can be the difference in a successful treatment.

Harmonyx offers testing for three classes of medication – Antiplatelets (Plavix® / clopidogrel), Statins (Zocor® / simvastatin) and ADHD. To learn more about Harmonyx or to find a Harmonyx pharmacy in your area, visit http://www.harmonyxdiagnostics.com.